Replies to post #26419 on OncoSec Medical Inc (ONCSQ)

[cameron12x]

Agreed. What affect, if any, will it have on our monthly burn rate?

[lasers]

$ONCS Combo P2B IMO 80 to 120 Patients for 1 year and follow up into the 2nd year would be my guessestimate for this Pivotal Phase2B Combo depending on the FDA agreed Protocol. Cost approx $20,000 to $30,000 per person which would be $2.4 mil to $3.6 mil for the 120 persons.

[furbush87]

I have two thoughts on that, If the trial size is 60-100, then I can't imagine they are planning on seeking approval after this trial is over. If the trial size is closer to 150, that would be a big indicator to me that they are hoping to get approved off of this trial.
Merck is likely taking care of any costs related to Keytruda, so ONCS should have limited costs, UCSF is likely paying for staff salaries, with a small fee for facilities and other items. This should be cheaper than ONCS doing it themselves, and probably equivalent in costs to the 3 trials ONCS currently has (MCC 15pateints T-Cell 15 patients, Melanoma 30 patients)